IBT
International Biotechnology Trust Portfolio holdings
AUM
$297M
This Quarter Return
-4.35%
1 Year Return
+17.25%
3 Year Return
+11.14%
5 Year Return
+79.35%
10 Year Return
–
AUM
$222M
AUM Growth
–
Cap. Flow
+$222M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
61.86%
Holding
49
New
49
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
CELG
Celgene Corp
CELG
|
$21M |
| 2 |
Biogen
BIIB
|
$18.7M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$16.4M |
| 4 |
SHPG
Shire pic
SHPG
|
$16.2M |
| 5 |
TSRO
TESARO, Inc.
TSRO
|
$12.7M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 93.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CELG
1
DELISTED
Celgene Corp
CELG
| $21M | 9.48% | +181,722 | New | +$21M |
|
|
2
Biogen
BIIB
$19.4B
| $18.7M | 8.42% | +65,908 | New | +$18.7M |
|
|
ALXN
3
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $16.4M | 7.38% | +133,841 | New | +$16.4M |
|
|
SHPG
4
DELISTED
Shire pic
SHPG
| $16.2M | 7.31% | +95,200 | New | +$16.2M |
|
|
TSRO
5
DELISTED
TESARO, Inc.
TSRO
| $12.7M | 5.72% | +94,500 | New | +$12.7M |
|
6
Gilead Sciences
GILD
$140B
| $12.6M | 5.67% | +175,784 | New | +$12.6M |
|
7
Regeneron Pharmaceuticals
REGN
$61.5B
| $11.9M | 5.37% | +32,430 | New | +$11.9M |
|
8
Amgen
AMGN
$155B
| $11.7M | 5.28% | +80,104 | New | +$11.7M |
|
|
ARIA
9
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $8.18M | 3.69% | +657,912 | New | +$8.18M |
|
10
Incyte
INCY
$16.5B
| $7.9M | 3.56% | +78,775 | New | +$7.9M |
|
11
Vertex Pharmaceuticals
VRTX
$100B
| $7.78M | 3.5% | +105,522 | New | +$7.78M |
|
|
ENTL
12
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
| $7.63M | 3.44% | +403,320 | New | +$7.63M |
|
13
Illumina
ILMN
$15.8B
| $7.16M | 3.23% | +55,941 | New | +$7.16M |
|
14
BioMarin Pharmaceuticals
BMRN
$11.2B
| $6.27M | 2.82% | +75,666 | New | +$6.27M |
|
|
AERI
15
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $5.21M | 2.35% | +138,000 | New | +$5.21M |
|
|
CLVS
16
DELISTED
Clovis Oncology, Inc.
CLVS
| $3.33M | 1.5% | +75,000 | New | +$3.33M |
|
|
ICPT
17
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $3.21M | 1.45% | +29,555 | New | +$3.21M |
|
|
ADMS
18
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $3.13M | 1.41% | +185,234 | New | +$3.13M |
|
19
Ligand Pharmaceuticals
LGND
$3.15B
| $3.05M | 1.37% | +30,000 | New | +$3.05M |
|
20
Exelixis
EXEL
$10.1B
| $2.76M | 1.24% | +185,000 | New | +$2.76M |
|
|
FOMX
21
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $2.2M | 0.99% | +197,838 | New | +$2.2M |
|
22
KalVista Pharmaceuticals
KALV
$678M
| $2.19M | 0.98% | +322,436 | New | +$2.19M |
|
23
Vanda Pharmaceuticals
VNDA
$279M
| $2.17M | 0.98% | +135,817 | New | +$2.17M |
|
24
Prothena Corp
PRTA
$441M
| $2.07M | 0.93% | +42,000 | New | +$2.07M |
|
25
Jazz Pharmaceuticals
JAZZ
$7.75B
| $1.98M | 0.89% | +18,200 | New | +$1.98M |
|